These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31820716)

  • 1. Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.
    Demir S; Soyer O; Bilginer Y; Sag E; Sahiner UM; Buyuktiryaki B; Sekerel BE; Ozen S
    Clin Exp Rheumatol; 2020; 38(3):552-557. PubMed ID: 31820716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
    Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
    Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
    Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
    Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hypersensitivity reactions to biological drugs in children with rheumatic diseases.
    Soyer O; Demir S; Bilginer Y; Batu ED; Sonmez HE; Arıcı ZS; Şahiner ÜM; Sekerel BE; Ozen S
    Pediatr Allergy Immunol; 2019 Dec; 30(8):833-840. PubMed ID: 31419311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.
    Giavina-Bianchi P; Galvão VR; Picard M; Caiado J; Castells MC
    J Allergy Clin Immunol Pract; 2017; 5(3):728-736. PubMed ID: 28034549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Castleman's disease: Rapid desensitization for hypersensitivity reaction to rituximab].
    Boin C; Lambert S; Thomann P; Aujoulat O; Kieffer P
    Rev Med Interne; 2016 Jun; 37(6):433-6. PubMed ID: 26415921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.
    Madrigal-Burgaleta R; Bernal-Rubio L; Berges-Gimeno MP; Carpio-Escalona LV; Gehlhaar P; Alvarez-Cuesta E
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):618-632. PubMed ID: 30098410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of rapid drug desensitization in children.
    Esenboga S; Akarsu A; Ocak M; Gur Cetinkaya P; Sahiner UM; Sekerel BE; Soyer O
    Pediatr Allergy Immunol; 2022 Mar; 33(3):e13759. PubMed ID: 35338724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.
    Goksel O; Goksel T; Cok G; Karakus H; Bacakoglu F; Goker E; Uslu R; Erdinc M
    Int J Clin Oncol; 2015 Apr; 20(2):395-404. PubMed ID: 25056643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity to biological agents-updated diagnosis, management, and treatment.
    Galvão VR; Castells MC
    J Allergy Clin Immunol Pract; 2015; 3(2):175-85; quiz 186. PubMed ID: 25754718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab desensitization in three patients with severe rituximab allergy.
    Öztürk E; Özyiğit LP; Öztürk AB; Akay MO; Çetiner M; Ferhanoğlu B
    Curr Probl Cancer; 2017; 41(5):349-354. PubMed ID: 28860080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.
    Gorgulu Akin B; Erkoc M; Korkmaz ET; Ozdel Ozturk B; Colak S; Ozalp Ates FS; Bavbek S
    World Allergy Organ J; 2022 Jan; 15(1):100619. PubMed ID: 34992710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.
    Kuo JC; Hawkins C; Yip D
    Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis.
    Vultaggio A; Nencini F; Bormioli S; Silvestri E; Dies L; Vivarelli E; Maggi E; Matucci A
    Sci Rep; 2021 Jun; 11(1):12558. PubMed ID: 34131173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Antihistamines and Corticosteroids as Premedication in Rapid Drug Desensitization to Paclitaxel: Outcomes in 155 Procedures.
    Lopez-Gonzalez P; Madrigal-Burgaleta R; Carpio-Escalona LV; Bernal-Rubio L; Guerra E; Berges-Gimeno MP; Alvarez-Cuesta E
    J Allergy Clin Immunol Pract; 2018; 6(4):1356-1362. PubMed ID: 29248386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis to tocilizumab in patients with rheumatic disease.
    Nam SH; Lim DH; Heo HM; Oh JS; Kwon HS; Kim TB; Ahn SM; Hong S; Lee CK; Yoo B; Kim YG
    Immunotherapy; 2021 Dec; 13(18):1483-1489. PubMed ID: 34657472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity reactions during treatment with biological agents.
    Puxeddu I; Caltran E; Rocchi V; Del Corso I; Tavoni A; Migliorini P
    Clin Exp Rheumatol; 2016; 34(1):129-32. PubMed ID: 26751942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms.
    Wong JT; Long A
    J Allergy Clin Immunol Pract; 2017; 5(6):1564-1571. PubMed ID: 29122155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab desensitization in pediatric acute lymphoblastic leukemia with severe anaphylaxis.
    V Villarreal-González R; E de Lira-Quezada C; N González-Díaz S; L Carrasco-Díaz L; González-Llano O
    J Oncol Pharm Pract; 2021 Apr; 27(3):747-750. PubMed ID: 32787558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.